Clinical Nutrition Market size to surpass $128 Bn by 2032

Clinical Nutrition Market size is slated to cross USD 128 billion by 2032, according to a new research report by Global Market Insights Inc.
 

A rising global birth rate is elevating the prevalence of premature birth, shaping the industry scenario as a result. A major concern with infants born prematurely is malnourishment, which can pose major health risk for the baby. The lack of nourishment is often an underlying contributor that makes babies prone to severe diseases. These global circumstances have created an ideal opportunity for the clinical nutrition market to draw revenues from infant nutrition.
 

Growing occurrence of metabolic disorders to stimulate application segment growth

The clinical nutrition industry from metabolic disorders is expected to surpass USD 40 billion by 2032. The segment outlook is primarily driven by the surging cases of metabolic disorders, particularly among the adult and the elderly population. Occurrence of metabolic diseases such as diabetes is increasing rapidly in many nations, bolstered demand for nutritional support, which is of immense importance for managing such diseases. Nutrition change that can support a 7-10% weight loss people with prediabetes is a key factor behind controlling the global diabetes case count.
 

Convenience and affordability to bring more demand for online distribution channels

The clinical nutrition market revenue from online channels is anticipated to surpass USD 22.5 billion by 2032. Customers find online channels more convenient and affordable alternatives, which is driving the segment gains. To cater to increasing demand, many players have started to roll-out their own online platforms, further shaping the industry scenario. Consumer preference has also dramatically shifted to online channels since the COVID-19 pandemic. In fact, as per the latest UNCTAD figures, the average share of internet users who shopped online increased from 53% in 2019 to 60% in 2020/21 across 66 nations following the pandemic.
 

Browse key industry insights spread across 330 pages with 662 market data tables & 17 figures & charts from the report, “Clinical Nutrition Market Size By Product (Infant Nutrition {Milk Based, Soy Based, Organic Formulas}, Enteral Nutrition {Standard Composition, Disease Specific Composition}, Parenteral Nutrition {Amino Acids, Fats, Carbohydrates}), By Consumer (Pediatric, Adult), By Application (Cancer, Metabolic Disorders, Neurological Diseases, Gastrointestinal Disorders), By Distribution Channel (Retail Stores, Pharmacies & Drug Stores, Online Channels), By Dosage Formulation (Powder, Liquid, Solid), Industry Analysis Report, Application Potential, Competitive Market Share & Forecast, 2023 – 2032” In detail along with the table of contents:
https://www.gminsights.com/industry-analysis/clinical-nutrition-market
 

Better absorption to shift preferences towards liquid dosage formulation segment

The clinical nutrition market share from liquid formulations is poised to cross USD 63.5 billion by 2032. Liquid doses offer quick supplementation as they can be swallowed easily and also have a higher caloric value. People suffering from cancer and gastrointestinal diseases commonly use liquid nutritional products to fulfil their nutritional requirements. Liquid supplements can also be absorbed easily as they take less time to break down, which makes them better suited for patients that cannot afford to expend too much energy on digestion.
 

Increasing geriatric population to strengthen Asia Pacific industry landscape

Asia Pacific clinical nutrition market valuation is slated to grow beyond USD 46.5 billion by 2032, on account of growing elderly population in the region. The higher geriatric demographic creates more impetus for product adoption. Meanwhile, regional outlook can also be attributed to the rising occurrence of chronic diseases, which has increased the number of people suffering from malnutrition.
 

As per World Food Programme (WFP), there are approximately 150 million under-nourished people in China alone, with 25% of this number being overweight, 19.6% being anemic, and 9.4% children with stunted progress. Favorable initiatives by the Chinese government and market leaders with a presence in the region are likely to improve the situation.
 

Mergers and acquisitions to outline the competitive landscape

Some leading clinical nutrition industry players include Danone, AYMES International Ltd, Medifood International Ltd, BASF SE, Meiji Holdings Co Ltd, Hero Nutritionals Inc, and Royal DSM, among others.